BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IAS-USA//NONSGML PDA Calendar Version 1.0//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:5e511cf91a39b57b95d1676665f4bfc5
ORGANIZER:registration@iasusa.org
DTSTAMP:20261026T212011Z
LOCATION:
SUMMARY:Liver Transplant Among People With HIV
DESCRIPTION:Overview\n\nAssessment of Needs\nThis webinar will discuss the evolving landscape of end-stage liver disease among people with HIV (PWH) and indications for liver transplantation.  It will review the improved outcomes of liver transplantation in this population in the recent era\, as well as barriers to access and potential challenges after transplant.\nLearning Objectives\nUpon completion of this webinar\, learners will be able to:\n\n 	Identify people with HIV (PWH) who should be referred for liver transplantation\n 	Describe outcomes of liver transplantation among PWH\n 	Identify management strategies to reduce potential complications of liver transplantation in PWH\n\nRegistration\nNote: The IAS–USA acknowledges the importance of delivering the same high-quality education and resources to our audiences despite the challenging times we are experiencing due to the COVID-19 pandemic. In response\, the implementation of a nominal fee to process the claim of CME and CE credits for webinars has been postponed.\nWho Should Attend\nThis advanced webinar is designed for clinical decision makers who are actively involved in HIV care and research.\n\nThis activity is also relevant for registered nurses\, PharmDs\, and other health professionals.\n\nIndividual registration is required\, even if you are viewing as a group\, in order to receive CME credit or a certificate of participation.\n\nRegistration closes on Monday\, August 24\, 2020\, 4:00 PM (PT).\n\nCertificates will be available after the completion of the evaluation and claim form.\n\nFor more information or questions\, please contact the registration department at registration@iasusa.org or 415-544-9400.\nConflicts of Interest\nIn the interest of maintaining the independence of its CME activities\, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME)\, the IAS–USA requires all persons with control of content (eg\, faculty\, IAS–USA Board members\, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.\n\nThe ACCME defines a commercial interest as “any entity producing\, marketing\, re-selling\, or distributing health care goods or services consumed by\, or used on\, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical service is owned\, or controlled by\, an ACCME-defined commercial interest.”\n\nPresenter\n\nDr Durand has received grant support from AbbVie and GlaxoSmithKline\; and has received study drugs and served on a grant review committee for Gilead Sciences\, Inc. (Updated 7/31/20)\n\nPlanner/Reviewer\n\nPlanner/Reviewer 1 has no relevant financial affiliations to disclose. (Updated 08/04/20)\nPlanner/Reviewer 2 has no relevant financial affiliations to disclose. (Updated 08/18/20)\n\n\n\n\nContinuing Education Credits\n\nCME Credits\nThe International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.\n\nThe IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.\nNursing Credits\nEducational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association\, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Provider # 5-115. This program is approved for 1.25 hours of continuing nursing education.\n\nEducational Review Systems is also approved for nursing continuing education by the state of California\, the state of Florida and the District of Columbia.\nPharmacy Credits\n Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 1.25 contact hours (0.125 CEU) submitted to CPE Monitor as early as 14 days after the event and no later than 60 days after the event. Please know that if accurate e-Profile information is not provided within 60 days of the event\, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.\n\nUAN # 0761-9999-20-094-L02-P\n\n\n\n\nGrant Support\n\n\nThis activity is part of the IAS–USA national educational effort that is funded\, in part\, by charitable contributions from commercial companies. Per IAS–USA policy\, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity\, including its content\, development\, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.\n\nPLATINUM SUPPORTERS\n\nGilead Sciences\, Inc\nMerck &amp\; Co\, Inc\nViiV Healthcare\n\nSILVER SUPPORTER\n\nJanssen Therapeutics\nFrequently Asked Questions\nView our list of FAQs about attending a webinar.\n\nFurther Questions?\nPlease contact the registration department at registration@iasusa.org or 415-544-9400.
STATUS:CONFIRMED
CATEGORIES:Webinars
URL;VALUE=URI:https://www.iasusa.org/events/webinar-2020-durand/
DTSTART:20200825T170000Z
DTEND:20200825T181500Z
END:VEVENT
END:VCALENDAR